| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |